LGD-1331
An investigational selective androgen receptor modulator
LGD-1331 is an investigational selective androgen receptor modulator (SARM) that is being studied for its potential use in treating conditions such as muscle wasting and osteoporosis. SARMs are a class of therapeutic compounds that have similar properties to anabolic agents, but with reduced androgenic (producing male characteristics) properties. This makes them potentially useful for a variety of medical conditions without the side effects associated with traditional anabolic steroids.
Mechanism of Action[edit | edit source]
LGD-1331 works by selectively binding to androgen receptors in the body. Unlike traditional anabolic steroids, which can affect many tissues, SARMs like LGD-1331 are designed to target specific tissues such as muscle and bone. This selective action is thought to reduce the risk of side effects while still providing the benefits of increased muscle mass and bone density.
Potential Benefits[edit | edit source]
Muscle Wasting: LGD-1331 is being investigated for its ability to prevent muscle wasting in patients with chronic illnesses such as cancer or HIV/AIDS.
Osteoporosis: The compound may also help in increasing bone density, making it a potential treatment for osteoporosis, a condition characterized by weak and brittle bones.
Clinical Trials[edit | edit source]
As of the latest updates, LGD-1331 is in the early stages of clinical trials. These trials are designed to assess the safety, tolerability, and efficacy of the compound in humans. Preliminary results have shown promise, but more research is needed to fully understand the potential of LGD-1331.
Side Effects[edit | edit source]
While SARMs are generally considered to have fewer side effects than traditional anabolic steroids, potential side effects of LGD-1331 may include:
- Hormonal imbalances
- Liver toxicity
- Cardiovascular issues
Regulatory Status[edit | edit source]
LGD-1331 is not currently approved for use by any major health regulatory body such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA). It is considered a research chemical and is primarily used in clinical research settings.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
